NantCell Buys VivaBioCell, Backed By $75M In New Funding

Los Angeles-based NantCell, one of the companies that is part of Dr. Patrick Soon-Shiong's NantWorks, said today that it has acquired an Italian company, VivaBioCell SpA. Financial terms of the deal wer enott disclosed. VivaBioCell is based in Udine, Northern Italy. The deal was done through VBC Holdings LLC, a subsidiary of NantWorks. VivaBioCell focuses on stem cell and tissue engineering for regenerative medicine. NantCell recently disclosed a $75.0M investment in the company from a single investor, although the company has yet to announce any details of that investment.